Joseph Farley
Neuroscience · Indiana University
Publications
78
Citations
2,105
Est. group size
—
Recurring co-author estimate
Active years
52
Publishing since 1975
Joseph Farley studies how proteins and peptides affect the electrical signaling of nerve cells, focusing on ion channels (the pores that let charged particles move in and out of neurons) and receptors that respond to neurotransmitters. Recent work examines how the amyloid beta peptide, which is linked to Alzheimer's disease, alters potassium channels and nicotinic acetylcholine receptors, along with related questions about disease-associated peptides.
Publication activity has been fairly steady over the past decade, averaging around two papers per year with modest year-to-year variation.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- BPS2025 - Tyrosine kinase-dependent suppression of Kv1.2 containing channels by amyloid β(1-42) peptide: Critical role of Y132
Biophysical Journal · 2025
- Calcium- and PTK-dependent suppression of macroscopic homomeric Kv1.1, Kv1.2, and heteromeric Kv1.1/1.2 currents by Aβ(1-42) peptide: Implications for Alzheimer’s disease
Biophysical Journal · 2024
- Differential modulation of alpha 7 nicotinic achrs by picomolar vs. high nanomolar or micromolar concentrations of amyloid beta 42 peptide
Biophysical Journal · 2023
- SARS-CoV-2 S1 spike protein peptides inhibit alpha 7 nAChRs and are counteracted by a PAM at alpha 7
Biophysical Journal · 2022
- Biophysical Journal×11
- Alzheimer s & Dementia×8
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile